Saul Faust to Humans
This is a "connection" page, showing publications Saul Faust has written about Humans.
Connection Strength
0.103
-
It's Time to Put Children and Young People First During the Global COVID-19 Pandemic. JAMA Pediatr. 2021 02 01; 175(2):127-128.
Score: 0.007
-
COVID-19 in children: current evidence and key questions. Curr Opin Infect Dis. 2020 12; 33(6):540-547.
Score: 0.007
-
Children are not COVID-19 super spreaders: time to go back to school. Arch Dis Child. 2020 07; 105(7):618-619.
Score: 0.007
-
Diagnosis and treatment of biofilm infections in children. Curr Opin Infect Dis. 2019 10; 32(5):505-509.
Score: 0.007
-
The Impact of Pediatric Outpatient Parenteral Antibiotic Therapy Implementation at a Tertiary Children's Hospital in the United Kingdom. Pediatr Infect Dis J. 2018 12; 37(12):e292-e297.
Score: 0.006
-
Good outlook for patients with confirmed Lyme neuroborreliosis. BMJ. 2018 05 30; 361:k2284.
Score: 0.006
-
Evidence base for the use of corticosteroids in septic shock in children. Crit Care Med. 2014 Jan; 42(1):e83-4.
Score: 0.005
-
Managing bone and joint infection in children. Arch Dis Child. 2012 Jun; 97(6):545-53.
Score: 0.004
-
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children in Summer Schools Applying Stringent Control Measures in Barcelona, Spain. Clin Infect Dis. 2022 01 07; 74(1):66-73.
Score: 0.002
-
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021 09 04; 398(10303):856-869.
Score: 0.002
-
Lupus, vaccinations and COVID-19: What we know now. Lupus. 2021 Sep; 30(10):1541-1552.
Score: 0.002
-
Paediatric research in the times of COVID-19. Pediatr Res. 2021 08; 90(2):267-271.
Score: 0.002
-
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021 04 10; 397(10282):1351-1362.
Score: 0.002
-
COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study. BMJ Open. 2021 03 17; 11(3):e044899.
Score: 0.002
-
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
Score: 0.002
-
Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study. BMJ Open. 2021 01 22; 11(1):e043012.
Score: 0.002
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
Score: 0.002
-
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021 12 19; 396(10267):1979-1993.
Score: 0.002
-
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Nov 19; 383(21):2030-2040.
Score: 0.002
-
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health. 2021 02; 5(2):133-141.
Score: 0.002
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020 08 15; 396(10249):467-478.
Score: 0.002
-
Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25; 384(8):693-704.
Score: 0.002
-
Microbial epidemiology and carriage studies for the evaluation of vaccines. J Med Microbiol. 2019 Oct; 68(10):1408-1418.
Score: 0.002
-
Congenital syphilis presenting with liver lesions. Int J STD AIDS. 2019 01; 30(1):82-85.
Score: 0.002
-
Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae. Microb Genom. 2018 09; 4(9).
Score: 0.002
-
Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function. Pediatrics. 2018 09; 142(3).
Score: 0.002
-
Ecology and diversity in upper respiratory tract microbial population structures from a cross-sectional community swabbing study. J Med Microbiol. 2018 Aug; 67(8):1096-1108.
Score: 0.002
-
Lyme disease: summary of NICE guidance. BMJ. 2018 Apr 12; 361:k1261.
Score: 0.002
-
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK. Vaccine. 2018 04 19; 36(17):2300-2306.
Score: 0.002
-
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase d Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase d Syndrome Registry. Front Immunol. 2018; 9:543.
Score: 0.002
-
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP. Sci Rep. 2018 02 21; 8(1):3390.
Score: 0.002
-
Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. Acta Obstet Gynecol Scand. 2018 Mar; 97(3):330-340.
Score: 0.002
-
Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation. J Allergy Clin Immunol. 2018 04; 141(4):1479-1482.e6.
Score: 0.001
-
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. JCI Insight. 2017 11 02; 2(21).
Score: 0.001
-
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis. Mol Ther. 2017 09 06; 25(9):2104-2116.
Score: 0.001
-
D-methionine interferes with non-typeable Haemophilus influenzae peptidoglycan synthesis during growth and biofilm formation. Microbiology (Reading). 2017 07; 163(7):1093-1104.
Score: 0.001
-
Pre-vaccine serotype composition within a lineage signposts its serotype replacement - a carriage study over 7 years following pneumococcal conjugate vaccine use in the UK. Microb Genom. 2017 06 30; 3(6):e000119.
Score: 0.001
-
Corticosteroids and infliximab impair the performance of interferon-? release assays used for diagnosis of latent tuberculosis. Thorax. 2017 10; 72(10):946-949.
Score: 0.001
-
The rise and fall of pneumococcal serotypes carried in the PCV era. Vaccine. 2017 03 01; 35(9):1293-1298.
Score: 0.001
-
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy. Vaccine. 2016 12 07; 34(50):6350-6357.
Score: 0.001
-
HIV-1 infection in children: current practice and future predictions. Adv Exp Med Biol. 2004; 549:135-48.
Score: 0.001